Exploring Medication Safety Practices in Anesthesia
July 30, 2026 updated by: Elizabeth Reine, Oslo University Hospital
Quality improvement project involving medication safety in anesthesia.
The study explores medication safety practices in anesthesia using a mixed methods approach.
Study Overview
Status
Completed
Conditions
Detailed Description
The present study has explored medication safety practices among nurse anesthestsists and anesthesiologists through structured and unstructured observations in clinical anesthesia practice.
The data is collected through non-participant observation using a guide consisting of the following topics: medications prepared, medication checking procedures, medications administered, team composition, interrutions and description of the workn environment
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway
- Department of nurse anesthesia, Oslo university hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Nurse anesthestists and anesthesiologists
Description
Inclusion criteria
- nurse anesthetist
- anesthesiologist
Exclusion Criteria:
- not involved in patient care
- not involved in medication handling
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Anesthesia providers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of medication checking procedures
Time Frame: November 2023 - May 2024
|
Description of medication checking procedures before or after patient arrival.
If independent double checking procedures are followed or not
|
November 2023 - May 2024
|
|
Description of medications prepared
Time Frame: November 2023 - May 2024
|
Detailed description of medications prepared during observation
|
November 2023 - May 2024
|
|
Description of medications administered
Time Frame: November 2023 until May 2024
|
Description of medications administered during anesthesia induction
|
November 2023 until May 2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of anesthesia team composition
Time Frame: November 2024 - May 2024
|
Description of number of nurse anesthestists and anesthesiologists present during observation
|
November 2024 - May 2024
|
|
Description of interupptions
Time Frame: November 2023 - May 2024
|
Detailed descriptions of possible interupptions and disturbances of work processes related to medication preparation or medication administration
|
November 2023 - May 2024
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of the environment
Time Frame: November 2023 - May 2024
|
Qualitative description the physical environment surrounding the work process of medication preparation and administration
|
November 2023 - May 2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Actual)
June 30, 2024
Study Completion (Actual)
May 30, 2026
Study Registration Dates
First Submitted
July 23, 2026
First Submitted That Met QC Criteria
July 30, 2026
First Posted (Actual)
July 31, 2026
Study Record Updates
Last Update Posted (Actual)
July 31, 2026
Last Update Submitted That Met QC Criteria
July 30, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 23/22765
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
If the data protection officer at the present hospital permits, parts of the anonymized data can be made avaliable in norwegian language upon request
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.